Soy intake is associated with lower endometrial cancer risk: A systematic review and meta-analysis of observational studies

Medicine (United States)

Volumn 94, Issue 50, 2015, Pages

  Zhang, Guo Qiang ^a   Chen, Jin Liang ^a   Liu, Qin ^a   Zhang, Yong ^a   Zeng, Huan ^a   Zhao, Yong ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHANIN A; DAIDZEIN; FLAVONOID; FORMONONETIN; GLYCITEIN; ISOFLAVONE; ISOFLAVONE DERIVATIVE;

ARTICLE; ASIAN; CANCER RISK; ENDOMETRIUM CANCER; FEMALE; FOOD INTAKE; HUMAN; META ANALYSIS; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; RISK FACTOR; RISK REDUCTION; SOY FOOD; SYSTEMATIC REVIEW; DIET; ENDOMETRIAL NEOPLASMS; OBSERVATIONAL STUDY;

DIET; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; OBSERVATIONAL STUDIES AS TOPIC; SOY FOODS;

EID: 84952665534     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000002281     Document Type: Article

References (70)

1. Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2014;136:E359-E386.
2. Amant F, Moerman P, Neven P, et al. Endometrial cancer. Lancet. 2005;366:491-505.
3. Key TJ, Pike MC. The dose-effect relationship between 'unopposed' oestrogens and endometrial mitotic rate: its central role in explaining and predicting endometrial cancer risk. Br J Cancer. 1988;57:205-212.
4. Siiteri PK. Steroid hormones and endometrial cancer. Cancer Res. 1978;38:4360-4366.
5. Beral V, Bull D, Reeves G. Endometrial cancer and hormonereplacement therapy in the Million Women Study. Lancet. 2005;365:1543-1551.
6. Parazzini F, La Vecchia C, Bocciolone L, et al. The epidemiology of endometrial cancer. Gynecol Oncol. 1991;41:1-16.
7. Ratajczak T, Twaddle E, Hahnel R. Sex hormone-binding globulin and estrogen receptor in endometrial and cervical cancer. Gynecol Oncol. 1980;10:262-266.
8. Kaaks R, Lukanova A, Kurzer MS. Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review. Cancer Epidemiol Biomarkers Prev. 2002;11:1531-1543.
9. Zhang JC, Xie ZB, Zai SF, et al. Matched case-control study for detecting risk factors of breast cancer in women living in Xinxiang, Henan Province. He Nan Zhong Liu Xue Za Zhi. 2003;16:201-203 (In Chinese).
10. Tao P, Yu XH, Liu L, et al. Gene polymorphism of estrogen receptor, dietary soy intake and breast cancer risk. Zhong Liu Yu Fang Yu Zhi Liao. 2015;28:8-12 (In Chinese).
11. Wuttke W, Jarry H, Seidlova-Wuttke D. Isoflavones-safe food additives or dangerous drugs? Ageing Res Rev. 2007;6:150-188.
12. Molteni A, Brizio-Molteni L, Persky V. In vitro hormonal effects of soybean isoflavones. J Nutr. 1995;125:751s-756s.
13. Baker ME. Endocrine activity of plant-derived compounds: an evolutionary perspective. Proc Soc Exp Biol Med. 1995;208:131-138.
14. Gao M, Cao YK, Xue XO. Effect of daidzein on proliferation of endometrial carcinoma. J Beijing Univ Traditional Chinese Med. 2010;33:162-165 (In Chinese).
15. Trock BJ, Hilakivi-Clarke L, Clarke R. Meta-analysis of soy intake and breast cancer risk. J Natl Cancer Inst. 2006;98:459-471.
16. Yang WS, Va P, Wong MY, et al. Soy intake is associated with lower lung cancer risk: results from a meta-analysis of epidemiologic studies. Am J Clin Nutr. 2011;94:1575-1583.
17. Van Die MD, Bone KM, Williams SG, et al. Soy and soy isoflavones in prostate cancer: a systematic review and meta-analysis of randomized controlled trials. BJU Int. 2014;113:E119-130.
18. Myung SK, Ju W, Choi HJ, et al. Soy intake and risk of endocrinerelated gynaecological cancer: a meta-analysis. BJOG. 2009;116:1697-1705.
19. Shen DP, Wang XP, Qin LQ. Isoflavones intake and risk of ovarian cancer: a meta-analysis of epidemiological study. Soybean Sci. 2013;32:814-817 (In Chinese).
20. Li XT, Hua L. Isoflavones intake and risk of breast cancer: a metaanalysis. J Math Med. 2015;28:53-56 (In Chinese).
21. Sampey BP, Lewis TD, Barbier CS, et al. Genistein effects on stromal cells determines epithelial proliferation in endometrial cocultures. Exp Mol Pathol. 2011;90:257-263.
22. Mylonas I, Jeschke U, Makovitzky J, et al. Immunohistochemical expression of steroid receptors and glycodelin A in isolated proliferative human endometrial glandular cells after stimulation with tamoxifen and phytoestrogens (genistein and daidzein). Anticancer Res. 2003;23:1119-1125.
23. Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Metaanalysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283:2008-2012.
24. Wells GA, Shea B, O'Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in metaanalyses. Available from: http://www.ohri.ca/programs/clinical-epidemiology/oxford.asp. (cited 12 October 2015).
25. Willett WC, Howe GR, Kushi LH. Adjustment for total energy intake in epidemiologic studies. Am J Clin Nutr. 1997;65:1220S-1228S.
26. Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557-560.
27. Horn-Ross PL, John EM, Canchola AJ, et al. Phytoestrogen intake and endometrial cancer risk. J Natl Cancer Inst. 2003;95:1158-1164.
28. Neill AS, Ibiebele TI, Lahmann PH, et al. Dietary phyto-oestrogens and the risk of ovarian and endometrial cancers: findings from two Australian case-control studies. Br J Nutr. 2014;111:1430-1440.
29. Horn R. Erratum: "Phytoestrogen intake and endometrial cancer risk" (Journal of the National Cancer Institute (2003) vol. 95 (1158-1164)). J Natl Cancer Inst. 2006;98:1501.
30. Bandera EV, Williams MG, Sima C, et al. Phytoestrogen consumption and endometrial cancer risk: a population-based case-control study in New Jersey. Cancer Causes Control. 2009;20:1117-1127.
31. Goodman MT, Wilkens LR, Hankin JH, et al. Association of soy and fiber consumption with the risk of endometrial cancer. Am J Epidemiol. 1997;146:294-306.
32. Hirose K, Tajima K, Hamajima N, et al. Subsite (cervix/endometrium) - specific risk and protective factors in uterus cancer. Jpn J Cancer Res. 1996;87:1001-1009.
33. Littman AJ, Beresford SA, White E. The association of dietary fat and plant foods with endometrial cancer (United States). Cancer Causes Control. 2001;12:691-702.
34. Rossi M, Edefonti V, Parpinel M, et al. Proanthocyanidins and other flavonoids in relation to endometrial cancer risk: a case-control study in Italy. Br J Cancer. 2013;109:1914-1920.
35. Xu WH, Zheng W, Cai Q, et al. The Asp327Asn polymorphism in the sex hormone-binding globulin gene modifies the association of soy food and tea intake with endometrial cancer risk. Nutr Cancer. 2008;60:736-743.
36. Ollberding NJ, Lim U, Wilkens LR, et al. Legume, soy, tofu, and isoflavone intake and endometrial cancer risk in postmenopausal women in the multiethnic cohort study. J Natl Cancer Inst. 2012;104:67-76.
37. Budhathoki S, Iwasaki M, Sawada N, et al. Soy food and isoflavone intake and endometrial cancer risk: the Japan Public Health Centerbased prospective study. BJOG. 2014;122:304-311.
38. Deming SL, Zheng W, Xu WH, et al. UGT1A1 genetic polymorphisms, endogenous estrogen exposure, soy food intake, and endometrial cancer risk. Cancer Epidemiol Biomarkers Prev. 2008;17:563-570.
39. Wang L, Lee IM, Zhang SM, et al. Dietary intake of selected flavonols, flavones, and flavonoid-rich foods and risk of cancer in middle-aged and older women. Am J Clin Nutr. 2009;89:905-912.
40. Goodman MT, Hankin JH, Wilkens LR, et al. Diet, body size, physical activity, and the risk of endometrial cancer. Cancer Res. 1997;57:5077-5085.
41. Xu WH, Zheng W, Xiang YB, et al. Soya food intake and risk of endometrial cancer among Chinese women in Shanghai: population based case-control study. BMJ. 2004;328:1285-1288.
42. Xu WH, Dai Q, Xiang YB, et al. Interaction of soy food and tea consumption with CYP19A1 genetic polymorphisms in the development of endometrial cancer. Am J Epidemiol. 2007;166:1420-1430.
43. Xu WH, Dai Q, Xiang YB, et al. Nutritional factors in relation to endometrial cancer: a report from a population-based case-control study in Shanghai, China. Int J Cancer. 2007;120:1776-1781.
44. Tao MH, Xu WH, Zheng W, et al. A case-control study in Shanghai of fruit and vegetable intake and endometrial cancer. Br J Cancer. 2005;92:2059-2064.
45. Dai Q, Xu WH, Long JR, et al. Interaction of soy and 17 (beta) - HSD1 gene polymorphisms in the risk of endometrial cancer. Pharmacogenet Genomics. 2007;17:161-167.
46. Utsunomiya H, Suzuki T, Harada N, et al. Analysis of estrogen receptor alpha and beta in endometrial carcinomas: correlation with ER beta and clinicopathologic findings in 45 cases. Int J Gynecol Pathol. 2000;19:335-341.
47. Pujol P, Rey JM, Nirde P, et al. Differential expression of estrogen receptor-alpha and -beta messenger RNAs as a potential marker of ovarian carcinogenesis. Cancer Res. 1998;58:5367-5373.
48. Matthews J, Gustafsson JA. Estrogen signaling: a subtle balance between ER alpha and ER beta. Mol Interv. 2003;3:281-292.
49. Li AJ, Baldwin RL, Karlan BY. Estrogen and progesterone receptor subtype expression in normal and malignant ovarian epithelial cell cultures. Am J Obstet Gynecol. 2003;189:22-27.
50. Chen GG, Zeng Q, Tse GM. Estrogen and its receptors in cancer. Med Res Rev. 2008;28:954-974.
51. Sarkar FH, Li Y. The role of isoflavones in cancer chemoprevention. Front Biosci. 2004;9:2714-2724.
52. Jarry H, Harnischfeger G, Duker E. [The endocrine effects of constituents of Cimicifuga racemosa. 2. In vitro binding of constituents to estrogen receptors]. Planta Med. 1985;4:316-319.
53. Hale GE, Hughes CL, Cline JM. Endometrial cancer: hormonal factors, the perimenopausal "window of risk", and isoflavones. J Clin Endocrinol Metab. 2002;87:3-15.
54. Adlercreutz H. Western diet and Western diseases: some hormonal and biochemical mechanisms and associations. Scand J Clin Lab Invest Suppl. 1990;201:3-23.
55. Rose DP. Dietary fiber, phytoestrogens, and breast cancer. Nutrition. 1992;8:47-51.
56. Adlercreutz H, Fotsis T, Heikkinen R, et al. Excretion of the lignans enterolactone and enterodiol and of equol in omnivorous and vegetarian postmenopausal women and in women with breast cancer. Lancet. 1982;2:1295-1299.
57. Setchell KD, Lawson AM, Borriello SP, et al. Lignan formation in man-microbial involvement and possible roles in relation to cancer. Lancet. 1981;2:4-7.
58. Setchell KD. Phytoestrogens: the biochemistry, physiology, and implications for human health of soy isoflavones. Am J Clin Nutr. 1998;68:1333s-1346s.
59. Adlercreutz H, Mousavi Y, Clark J, et al. Dietary phytoestrogens and cancer: in vitro and in vivo studies. J Steroid Biochem Mol Biol. 1992;41:331-337.
60. Adlercreutz H, Hockerstedt K, Bannwart C, et al. Effect of dietary components, including lignans and phytoestrogens, on enterohepatic circulation and liver metabolism of estrogens and on sex hormone binding globulin (SHBG). J Steroid Biochem. 1987;27:1135-1144.
61. Lu LJ, Anderson KE, Grady JJ, et al. Effects of soya consumption for one month on steroid hormones in premenopausal women: implications for breast cancer risk reduction. Cancer Epidemiol Biomarkers Prev. 1996;5:63-70.
62. Cassidy A, Bingham S, Setchell KD. Biological effects of a diet of soy protein rich in isoflavones on the menstrual cycle of premenopausal women. Am J Clin Nutr. 1994;60:333-340.
63. Kim J, Kang M, Lee JS, et al. Fermented and non-fermented soy food consumption and gastric cancer in Japanese and Korean populations: a meta-analysis of observational studies. Cancer Sci. 2011;102:231-244.
64. Kinouchi FL, Maia DC, De Abreu Ribeiro LC, et al. A soy-based product fermented by Enterococcus faecium and Lactobacillus helveticus inhibits the development of murine breast adenocarcinoma. Food Chem Toxicol. 2012;50:4144-4148.
65. Chang WH, Liu JJ, Chen CH, et al. Growth inhibition and induction of apoptosis in MCF-7 breast cancer cells by fermented soy milk. Nutr Cancer. 2002;43:214-226.
66. Ohara M, Lu H, Shiraki K, et al. Inhibition by long-term fermented miso of induction of gastric tumors by N-methyl-N0-nitro-N-nitrosoguanidine in CD (SD) rats. Oncol Rep. 2002;9:613-616.
67. Ohuchi Y, Myojin Y, Shimamoto F, et al. Decrease in size of azoxymethane induced colon carcinoma in F344 rats by 180-day fermented miso. Oncol Rep. 2005;14:1559-1564.
68. De Lemos ML. Effects of soy phytoestrogens genistein and daidzein on breast cancer growth. Ann Pharmacother. 2001;35:1118-1121.
69. Dampier K, Hudson EA, Howells LM, et al. Differences between human breast cell lines in susceptibility towards growth inhibition by genistein. Br J Cancer. 2001;85:618-624.
70. Unfer V, Casini ML, Costabile L, et al. Endometrial effects of longterm treatment with phytoestrogens: a randomized, double-blind, placebo-controlled study. Fertil Steril. 2004;82:145-148.